Richard G. Vincent

This profile gathers the share dealings of Richard G. Vincent in Oncternal Therapeutics, Inc., where the filings describe the role as finance chief. Between 7 June 2019 and 3 January 2024, the trades on record add up to 17 filings.

The open-market record is one-sided, with 9 purchases worth €34k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 8 share grants.

In size, the median ticket on the buying side is €3,184. Clusters matter here: 4 out of 9 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The newest entry dates from 5 January 2024: a share grant of €4,021, in Oncternal Therapeutics, Inc. The latest purchase dates back some time: it was published 1,289 days ago, on 14 April 2023. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.